STAAR Surgical Co (STAA) SEC filings

STAANasdaqOphthalmic GoodsFiscal year ends January 2

Financials through Q3 FY2026, quarter ended Oct 2, 2026Last filing: 10-Q on Nov 4, 2026Score 8/30

$26.78+0.09 (+0.34%)

Close on Nov 12, 2026Market cap $1.34BP/E –Yield –

SEC filings

40 of STAAR Surgical's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Quarterly report	10-Q	Oct 2, 2026	Nov 4, 2026	SEC EDGAR
Current report	8-K	Nov 4, 2026	Nov 4, 2026	SEC EDGAR
Current report	8-K	Sep 9, 2026	Sep 10, 2026	SEC EDGAR
Quarterly report	10-Q	Jul 3, 2026	Aug 12, 2026	SEC EDGAR
Current report	8-K	Aug 12, 2026	Aug 12, 2026	SEC EDGAR
Current report	8-K	Aug 5, 2026	Aug 6, 2026	SEC EDGAR
Current report	8-K	Jun 18, 2026	Jun 22, 2026	SEC EDGAR
Current report	8-K	Jun 9, 2026	Jun 9, 2026	SEC EDGAR
Quarterly report	10-Q	Apr 3, 2026	May 13, 2026	SEC EDGAR
Current report	8-K	May 12, 2026	May 13, 2026	SEC EDGAR
Proxy statement	DEF 14A	May 1, 2026	May 4, 2026	SEC EDGAR
Current report	8-K	Apr 8, 2026	Apr 8, 2026	SEC EDGAR
Current report	8-K	Mar 3, 2026	Mar 3, 2026	SEC EDGAR
Annual report	10-K	Jan 2, 2026	Mar 3, 2026	SEC EDGAR
Current report	8-K	Feb 5, 2026	Feb 5, 2026	SEC EDGAR
Current report	8-K	Feb 1, 2026	Feb 2, 2026	SEC EDGAR
Current report	8-K	Jan 15, 2026	Jan 16, 2026	SEC EDGAR
Current report	8-K	Jan 14, 2026	Jan 15, 2026	SEC EDGAR
Current report	8-K	Jan 6, 2026	Jan 6, 2026	SEC EDGAR
Current report	8-K	Jan 6, 2026	Jan 6, 2026	SEC EDGAR
Current report	8-K	Dec 9, 2025	Dec 9, 2025	SEC EDGAR
Current report	8-K	Dec 8, 2025	Dec 8, 2025	SEC EDGAR
Current report	8-K	Nov 7, 2025	Nov 7, 2025	SEC EDGAR
Quarterly report	10-Q	Sep 26, 2025	Nov 5, 2025	SEC EDGAR
Current report	8-K	Nov 5, 2025	Nov 5, 2025	SEC EDGAR
Current report	8-K	Oct 27, 2025	Oct 27, 2025	SEC EDGAR
Current report	8-K	Oct 23, 2025	Oct 23, 2025	SEC EDGAR
Current report	8-K	Oct 20, 2025	Oct 20, 2025	SEC EDGAR
Current report	8-K	Oct 13, 2025	Oct 14, 2025	SEC EDGAR
Current report	8-K	Sep 26, 2025	Sep 26, 2025	SEC EDGAR
Quarterly report	10-Q	Jun 27, 2025	Aug 6, 2025	SEC EDGAR
Current report	8-K	Aug 6, 2025	Aug 6, 2025	SEC EDGAR
Current report	8-K	Aug 4, 2025	Aug 5, 2025	SEC EDGAR
Current report	8-K	Jun 25, 2025	Jun 25, 2025	SEC EDGAR
Current report	8-K	Jun 18, 2025	Jun 18, 2025	SEC EDGAR
Current report	8-K	Jun 4, 2025	Jun 4, 2025	SEC EDGAR
Current report	8-K	May 16, 2025	May 16, 2025	SEC EDGAR
Quarterly report	10-Q	Mar 28, 2025	May 7, 2025	SEC EDGAR
Current report	8-K	May 7, 2025	May 7, 2025	SEC EDGAR
Proxy statement	DEF 14A	Apr 24, 2025	Apr 24, 2025	SEC EDGAR

Where these numbers come from

Parsed from the XBRL in STAAR Surgical's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-2 reverse split on May 18, 1992
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is STAA.

Compare: STAA vs RXST · STAA vs COO · STAA vs WRBY · STAA vs ALC · STAA vs BLCO

Revenue growth42.4% · median 8.9%

Gross margin73.6% · median 71.3%

Operating margin0.2% · median 7.1%

Net margin0.2% · median -0.6%

Company	Revenue	Growth
ALC	$7.18B	+10.5%
BLCO	$5.42B	+8.9%
COO	$4.24B	+4.7%
WRBY	$934.66M	+9.9%
STAA	$328.27M	+42.4%
RXST	$127.58M	-13.2%

Company

Next earnings (est.): Mar 2, 2027, after close
Exchange: Nasdaq
Industry: Ophthalmic Goods
Fiscal year ends: January 2
Employees: 957
Held by institutions: 100.0%
Auditor: BDO USA, P.C.
SEC CIK: 718937

Advertisement
300 × 250

See a number that looks wrong?